Literature DB >> 24976021

A nationwide survey on unilateral moyamoya disease in Japan.

Kentaro Hayashi1, Nobutaka Horie2, Tsuyoshi Izumo2, Izumi Nagata2.   

Abstract

OBJECTIVE: Moyamoya disease (MMD) is a unique occlusive disease of the bilateral internal carotid arteries; compensation for occlusion results in rich arterial collaterals at the base of the brain. The clinical features of unilateral MMD, confirmed by typical angiographic evidence of MMD unilaterally and normal or equivocal contralateral findings, are not well known. To identify the clinical features of unilateral MMD in Japan, a nationwide survey was conducted. PATIENTS AND METHODS: The questionnaire was directly mailed to 241 departments that reported treating unilateral MMD patients in a primary survey. We ascertained the sex, age, family history, clinical manifestation, radiological findings, treatments, course of the disease, and daily activity of unilateral MMD patients.
RESULTS: A total of 114 departments replied to the questionnaire. The data of 203 patients (118 female and 85 male; female to male ratio 1.4:1) were registered and analyzed. The mean age was 40.2 years old with a peak occurring in the fifties. Twenty-one patients (10.7%) exhibited familial MMD. The clinical symptoms are motor weakness 57 (26.8%), headache 37 (17.4%), transient ischemic attack 35 (16.4%), and no symptom 30 (14.1%). The MMD types determined by imaging included ischemic type in 64 patients (32.5%), bleeding type in 51 (25.9%), and normal in 82 (41.6%). The development of moyamoya vessels was mild in 78 patients (43.9%) and most patients (81.1%) were accompanied with cerebral hypoperfusion. Medical treatment or vascular reconstruction was employed for more than half of the patients.
CONCLUSION: The clinical feature of unilateral MMD was revealed in this nationwide study. Unilateral MMD was predominant in adults and the development of moyamoya vessel was relatively less prevalent.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epidemiology; Moyamoya disease; Nationwide survey; Stroke; Unilateral moyamoya disease

Mesh:

Year:  2014        PMID: 24976021     DOI: 10.1016/j.clineuro.2014.06.010

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  9 in total

1.  Ischemic and hemorrhagic moyamoya disease in adults: CT findings.

Authors:  Anming Xie; Li Luo; Yaojun Ding; Gongjie Li
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 2.  Significance of Cerebral Blood Flow Analysis in the Acute Stage after Revascularization Surgery for Moyamoya Disease.

Authors:  Miki Fujimura; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-09-15       Impact factor: 1.742

Review 3.  Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis.

Authors:  Jong S Kim
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

4.  The Efficacy of Single Barrel Superficial Temporal Artery-middle Cerebral Artery Bypass in Treatment of Adult Patients with Ischemic-type Moyamoya Disease.

Authors:  Mahnjeong Ha; Chang Hwa Choi; Jae Il Lee; Seung Heon Cha; Sang Weon Lee; Jun Kyeung Ko
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2016-09-30

5.  Analysis of the clinical characteristics of hemorrhagic moyamoya disease in the Jilin province of northeastern China: A single-center study of 212 cases.

Authors:  Qinglian Li; Lai Qu; Yongjie Yuan; Baofeng Xu; Yunbao Guo; Kan Xu; Jinlu Yu
Journal:  Biomed Rep       Date:  2017-12-15

Review 6.  Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.

Authors:  Xin Liao; Jing Deng; Wenjie Dai; Tong Zhang; Junxia Yan
Journal:  Environ Health Prev Med       Date:  2017-11-02       Impact factor: 3.674

7.  The contralateral progression in a cohort of Chinese adult patients with unilateral moyamoya disease after revascularization: a single-center long-term retrospective study.

Authors:  Xiao Tian; Miao Hu; Jianjian Zhang
Journal:  Acta Neurochir (Wien)       Date:  2022-03-26       Impact factor: 2.816

8.  Moyamoya disease associated with arteriovenous malformation and anterior communicating artery aneurysm: A case report and literature review.

Authors:  Jinlu Yu; Yongjie Yuan; Duoduo Zhang; Kan Xu
Journal:  Exp Ther Med       Date:  2016-04-21       Impact factor: 2.447

9.  Neurocognitive Dysfunction According to Hypoperfusion Territory in Patients With Moyamoya Disease.

Authors:  Chang Gu Kang; Min Ho Chun; Jung-A Kang; Kyung Hee Do; Su Jin Choi
Journal:  Ann Rehabil Med       Date:  2017-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.